Hosted on MSN23d
Sanofi stock price target raised to €120 by Leerink Partners
For deeper insights into Sanofi's financial health and growth prospects, access the comprehensive Pro Research Report ... to sell a controlling stake in Opella to CD&R for €16 billion, expected ...
Yahoo Finance4d
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share purchase agreement with buyer Clayton Dubilier & Rice (CD&R).
Sanofi to sell 50% stake in consumer health unit to CD&R
Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...
Drug Store News4d
Sanofi nears selling 50% controlling stake in Opella to CD&R
Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton ...
Press Release: Sanofi and CD&R sign Opella share purchase agreement
Sanofi and CD&R sign Opella share purchase agreementParis, February 19, 2025. Following completion of the required social and corporate ...